NSEGeneral Updates10h ago · 9 Sept 2026, 02:59 pm

General Updates

Sun Pharmaceutical Industries Limited · SUNPHARMA

✦ AI SummaryJoint Venture

Sun Pharmaceutical Industries Limited has informed the Exchange about the incorporation of a subsidiary company, Sun Pharma Global Treasury Centre IFSC Limited, in the International Financial Services Centre at GIFT City, Gandhinagar, Gujarat, India.

Analysis Scores

Earnings Impact2/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Sun Pharmaceutical Industries Limited has informed the Exchange about Incorporation of a Subsidiary Company

Attachments (1)

📄

SUNSEC_09092026145813_SEIntimationforGTCIncorporation.pdf

pdf

Download →
View document text
Sun Pharmaceutical Industries Limited Sun House, Plot No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai – 400 063, Maharashtra, INDIA. Tel.: (91-22) 4324 4324 Fax: (91-22) 4324 4343 Website: www.sunpharma.com Email: secretarial@sunpharma.com CIN: L24230GJ1993PLC019050 09 September 2026 National Stock Exchange of India Limited BSE Limited Scrip Symbol: SUNPHARMA Scrip Code: 524715 Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Incorporation of a Subsidiary Company This is to inform you that “Sun Pharma Global Treasury Centre IFSC Limited” has been incorporated on 08 September 2026 as an indirect wholly owned subsidiary of the Company in the International Financial Services Centre at GIFT City, Gandhinagar, Gujarat, India. The disclosures required under Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are enclosed as Annexure A. For Sun Pharmaceutical Industries Limited (Anoop Deshpande) Company Secretary and Compliance Officer ICSI Membership No.: A23983 Registered Office: SPARC, Tandalja, Vadodara – 390 012, Gujarat, INDIA. Reaching People. Touching Lives. Sun Pharmaceutical Industries Limited Sun House, Plot No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai – 400 063, Maharashtra, INDIA. Tel.: (91-22) 4324 4324 Fax: (91-22) 4324 4343 Website: www.sunpharma.com Email: secretarial@sunpharma.com CIN: L24230GJ1993PLC019050 Annexure A Disclosure under Para A of Part A of Schedule III to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Sl. No. Particulars Information a) Name of the target entity, details in brief such as Sun Pharma Global Treasury Centre IFSC size, turnover etc. Limited, an indirect wholly owned subsidiary of the Company, incorporated in GIFT City IFSC, Gandhinagar, Gujarat. Being newly incorporated, it has not commenced operations and has no turnover. b) Whether the acquisition would fall within related The entity has been newly incorporated as a party transaction(s) and whether the promoter/ wholly owned subsidiary of Sun Pharma promoter group/ group companies have any Laboratories Limited. interest in the entity being acquired? If yes, nature of interest and details thereof and whether the The promoter/promoter group has no interest same is done at “arm’s length” in the entity except through the Sun Pharma Group. c) Industry to which the entity being acquired Financial services, including global treasury belongs and cash management services. d) Objects and effects of acquisition (including but To operate as the Global Treasury Centre for not limited to, disclosure of reasons for the Sun Pharma Group and undertake acquisition of target entity, if its business is treasury, funding, liquidity, cash management outside the main line of business of the listed and other permissible financial activities. entity) e) Brief details of any governmental or regulatory Registration/approval from the International approvals required for the acquisition Financial Services Centres Authority will be obtained for undertaking the proposed activities in GIFT City IFSC. f) Indicative time period for completion of the Not applicable, as the entity has been newly acquisition incorporated. g) Nature of consideration - whether cash Subscription to the initial equity share capital consideration or share swap and details of the in cash. same h) Cost of acquisition or the price at which the Initial subscription to equity share capital of shares are acquired approximately INR. 9.50 Crore. i) Percentage of shareholding/ control acquired and/ 100%, held through Sun Pharma Laboratories or number of shares acquired Limited, including its nominee shareholders. j) Brief background about the entity acquired in Incorporated on 08 September 2026 in India terms of products/line of business acquired, date to operate as the Global Treasury Centre for of incorporation, history of last 3 years turnover, the Sun Pharma Group. Being newly country in which the acquired entity has presence incorporated, it has no operating history or and any other significant information (in brief) turnover. Registered Office: SPARC, Tandalja, Vadodara – 390 012, Gujarat, INDIA. Reaching People. Touching Lives.